نتائج البحث

1

PORTEC-4a

المساهمون: CCA - Cancer Treatment and Quality of Life, Radiotherapy, Radiotherapie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Targeted Gynaecologic Oncology (TARGON), Translational Immunology Groningen (TRIGR)

المصدر: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020(30), 2002-2007. BMJ Publishing Group
International journal of gynecological cancer, 30(12), 2002-2007. Wolters Kluwer Health
International Journal of Gynecological Cancer, 30, 12, pp. 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. BMJ Publishing Group
International Journal of Gynecological Cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
International Journal of Gynecological Cancer, 30, 2002-2007
International Journal of Gynecological Cancer, 30(12), 2002-2007. LIPPINCOTT WILLIAMS & WILKINS

مصطلحات موضوعية: medicine.medical_specialty, CARCINOMA, SURGERY, medicine.medical_treatment, Brachytherapy, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, SDG 3 - Good Health and Well-being, law, Internal medicine, Medicine and Health Sciences, medicine, Clinical endpoint, Humans, Multicenter Studies as Topic, External beam radiotherapy, Stage (cooking), endometrium, Adverse effect, Mismatch Repair Endonuclease PMS2, Randomized Controlled Trials as Topic, 030304 developmental biology, 0303 health sciences, business.industry, Endometrial cancer, Obstetrics and Gynecology, radiation oncology, medicine.disease, Clinical Trial, Endometrial Neoplasms, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], DNA-Binding Proteins, Radiation therapy, MutS Homolog 2 Protein, Clinical Trials, Phase III as Topic, Oncology, EXTERNAL-BEAM RADIOTHERAPY, 030220 oncology & carcinogenesis, Female, Radiotherapy, Adjuvant, MutL Protein Homolog 1, business, Carcinoma, Endometrioid

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57344841d5afbe302a24fc27474aae68Test
https://doi.org/10.1136/ijgc-2020-001929Test

2

Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair deficient metastatic colorectal cancer

المؤلفون: Pashtoon Murtaza Kasi, Griffin Budde, Michael Krainock, Vasily N Aushev, Allyson Koyen Malashevich, Meenakshi Malhotra, Perry Olshan, Paul R Billings, Alexey Aleshin

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, Cancer Research, tumor, combined modality therapy, Immunology, Programmed Cell Death 1 Receptor, Case Report, Antibodies, Monoclonal, Humanized, DNA Mismatch Repair, Circulating Tumor DNA, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Humans, Antigens, Tumor-Associated, Carbohydrate, CTLA-4 Antigen, RC254-282, Aged, Pharmacology, biomarkers, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, Ipilimumab, digestive system diseases, Carcinoembryonic Antigen, 2518 1619, Nivolumab, Oncology, Drug Resistance, Neoplasm, tumor biomarkers, Disease Progression, Molecular Medicine, Female, immunotherapy, Colorectal Neoplasms

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17cc2a8945f3bfcc3fe1efa9cda71feeTest
https://jitc.bmj.com/content/10Test/1/e003312.full

3

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

المساهمون: Institut Català de la Salut, [Oaknin A] Gynaecologic Cancer Programme, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Gilbert L] Department of Gynecologic Oncology, McGill University Health Centre Research Institute, Montreal, Quebec, Canada. [Tinker AV] Department of Medicine, BC Cancer, Vancouver, British Columbia, Canada. [Brown J] Division of Gynecologic Oncology, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA. [Mathews C] Department of Gynecological Oncology, Women and Infants Hospital of Rhode Island, Providence, Rhode Island, USA. [Press J] Gynecologic Oncology and Pelvic Surgery, Swedish Cancer Institute, Seattle, Washington State, USA, Vall d'Hebron Barcelona Hospital Campus, Department of Medical Oncology, Institut Paoli-Calmettes, 232 Boulevard Sainte Marguerite, 13009 Marseille, France., Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Scientia
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, 2022, 10 (1), pp.e003777. ⟨10.1136/jitc-2021-003777⟩

مصطلحات موضوعية: Cancer Research, Immunology, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], [SDV.CAN]Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Humanized, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized [CHEMICALS AND DRUGS], DNA Mismatch Repair, Endometri - Càncer - Tractament, programmed cell death 1 receptor, Biomarkers, Tumor, Humans, Immunology and Allergy, aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados [COMPUESTOS QUÍMICOS Y DROGAS], Other subheadings::/therapeutic use [Other subheadings], afecciones patológicas, signos y síntomas::procesos patológicos::inestabilidad genómica::inestabilidad de microsatélites [ENFERMEDADES], RC254-282, Clinical/Translational Cancer Immunotherapy, Satèl·lits (Genètica), Pharmacology, Pathological Conditions, Signs and Symptoms::Pathologic Processes::Genomic Instability::Microsatellite Instability [DISEASES], clinical trials as topic, Anticossos monoclonals - Ús terapèutic, Otros calificadores::/uso terapéutico [Otros calificadores], Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms [DISEASES], Middle Aged, Endometrial Neoplasms, Oncology, Molecular Medicine, Female, Microsatellite Instability, immunotherapy, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales [ENFERMEDADES]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d05449afa4e84daf1aeed6e17dd65d8Test
https://jitc.bmj.com/content/10Test/1/e003777.full

4

Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment

المؤلفون: Elisabetta Gambale, Sara Fancelli, Enrico Caliman, Maria Cristina Petrella, Laura Doni, Serena Pillozzi, Lorenzo Antonuzzo

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da09d47c5cfe7cbdd1d98697d9286288Test
http://europepmc.org/articles/PMC8804682Test

5

Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments

المؤلفون: Julia Moreno-Vicente, Jane E Willoughby, Martin C Taylor, Steven G Booth, Vikki L English, Emily L Williams, Christine A Penfold, C Ian Mockridge, Tatyana Inzhelevskaya, Jinny Kim, H T Claude Chan, Mark S Cragg, Juliet C Gray, Stephen A Beers

المساهمون: Moreno-Vicente, Julia [0000-0002-1740-9350], Willoughby, Jane E [0000-0002-6326-4519], Apollo - University of Cambridge Repository

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Journal for Immunotherapy of Cancer

وصف الملف: application/pdf; text/xml; text

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc1d40f038ae30462935179ccdb7a35Test
https://jitc.bmj.com/content/10Test/1/e003735.full

6

Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors

المؤلفون: Cristescu, Razvan, Aurora-Garg, Deepti, Albright, Andrew, Xu, Lei, Liu, Xiao Qiao, Loboda, Andrey, Lang, Lixin, Jin, Fan, Rubin, Eric H, Snyder, Alexandra, Lunceford, Jared

المصدر: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 1 (2022)
Journal for Immunotherapy of Cancer

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5784091fc8e83af247dd530be681401eTest
https://jitc.bmj.com/content/10Test/1/e003091.full

7

Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

المؤلفون: Stefano Gambera, Javier García-Castro, Angela Leo, Alvaro Morales-Molina

المساهمون: Asociación Pablo Ugarte contra el cáncer infantil, Asociación de Familias de Niños con Cáncer de Castilla-La Mancha, Instituto de Salud Carlos III, Comunidad de Madrid (España), Fundación Oncohematología Infantil, Asociación Pablo Ugarte, AFANION, Instituto de Salud Carlos III - ISCIII, Comunidad de Madrid, Fundación Oncohematología Infantil Asociación Pablo Ugarte

المصدر: Journal for Immunotherapy of Cancer
Repisalud
Instituto de Salud Carlos III (ISCIII)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 3 (2021)

مصطلحات موضوعية: lymphocytes, Cancer Research, medicine.medical_treatment, T-Lymphocytes, Immunomodulating Agents, Cytopathogenic Effect, Viral, Databases, Genetic, Granulocyte Colony-Stimulating Factor, Tumor Microenvironment, Immunology and Allergy, Lymphocytes, Oncolytic virotherapy, oncolytic virotherapy, RC254-282, Mice, Inbred BALB C, Osteosarcoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, Oncolytic Viruses, medicine.anatomical_structure, Oncology, Molecular Medicine, immunotherapy, Immunotherapy, T cell, Immunology, Bone Neoplasms, Mesenchymal Stem Cell Transplantation, programmed cell death 1 receptor, Adenoviridae, Immune system, Lymphocytes, Tumor-Infiltrating, Cell Line, Tumor, medicine, Animals, Humans, Virotherapy, t-lymphocytes, Pharmacology, business.industry, Mesenchymal stem cell, Programmed cell death 1 receptor, Mesenchymal Stem Cells, tumor-infiltrating, medicine.disease, Oncolytic virus, Oncolytic and Local Immunotherapy, Cancer cell, Cancer research, Tumor-infiltrating, business